GeoVax Recent News

GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update

 
News Release Takeaways
  • Cancer Immunotherapy – Collaborations with University of Pittsburgh and ViaMune, Inc.,Vaxeal Holding SA., Emory University and Leidos, Inc.
  • HIV “Functional Cure” Immunotherapy – We are participating in a planned clinical trialled by researchers at American Gene Technologies (AGT) (www.americangene.com), to develop a therapy aimed at eliminating HIV from infected people.
  • HIV Preventive Vaccine – We are planning for a new Phase 1 human clinical trial with operational support from the HIV Vaccine Trials Network (HVTN) and funding from the National Institute of Allergy and Infectious Diseases (NIAID).  

Written by : GeoVax

Copyright © GeoVax 2019. All Rights Reserved.

Search